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ABSTRACT
The activation of a telomere maintenance mecha-
nism is required for cancer development in humans.
While most tumors achieve this by expressing the
enzyme telomerase, a fraction (5–15%) employs
a recombination-based mechanism termed alter-
native lengthening of telomeres (ALT). Here we
show that loss of the single-stranded DNA-binding
protein replication protein A (RPA) in human ALT
cells, but not in telomerase-positive cells, causes
increased exposure of single-stranded G-rich
telomeric DNA, cell cycle arrest in G2/M phase,
accumulation of single-stranded telomeric DNA
within ALT-associated PML bodies (APBs), and
formation of telomeric aggregates at the ends of
metaphase chromosomes. This study demonstrates
differences between ALT cells and telomerase-
positive cells in the requirement for RPA in telomere
processing and implicates the ALT mechanism in
tumor cells as a possible therapeutic target.
INTRODUCTION
Telomeres are specialized protein–DNA complexes at the
ends of linear chromosomes. They consist of arrays of
the hexameric nucleotide sequence 50-TTAGGG-30 and
a number of telomere-associated proteins that function in
telomere length regulation or protection of the chromo-
somal ends from degradation or inappropriate recombi-
nation events (1).
Several features distinguish telomeres in alternative
lengthening of telomeres (ALT) cells from those of
normal cells or telomerase-positive tumor cells. First,
while telomerase-positive cells contain telomeres of roughly
the same length, telomeres in ALT cells exhibit a high
degree of length heterogeneity ranging from critically short
to abnormally long (2). Second, ALT cells, but not
telomerase-positive cells, contain extrachromosomal
circular and linear DNA in addition to telomeres at
the chromosomal ends. It is not clear whether these
extrachromosomal DNA species simply represent
by-products of the telomere recombination activities that
take place in ALT cells or if they play an active role in
telomere elongation (3–6). Finally, ALT cells have been
found to contain special promyelocytic leukemia-nuclear
bodies (PML-NBs) termed ALT-associated PML bodies
(APBs) (7). These structures contain telomeric DNA,
telomere-binding proteins and several proteins with
known functions in DNA repair and recombination.
A recent study revealed that a proportion of the telomeric
DNA that was retained in partially puriﬁed APBs is of
extrachromosomal origin (8). It has not been determined,
however, ifthese structuresalso contain genomic telomeres.
Replication protein A (RPA) plays crucial roles in
DNA metabolic processes such as recombination, replica-
tion and repair (9,10). It is also becoming increasingly
clear that this protein is both structurally and functionally
related to a family of single-stranded telomere-binding
proteins which include POT1-TPP1 in mammals, Pot1 in
ﬁssion yeast, Cdc13-Stn1-Ten1 in budding yeast and
TEBP in ciliated protozoan (11,12). For example, similar
to the single-stranded telomere-binding proteins, all three
RPA subunits (RPA14, RPA32 and RPA70) contain
oligonucleotide/oligosaccharide-binding folds (OB-folds)
that facilitate single-stranded DNA binding (9). Further-
more, in vitro studies have shown that RPA is able to bind
and unfold the telomeric G-rich 30 overhangs in a manner
similar to that of human POT1 (13,14). Moreover, RPA in
Saccharomyces cerevisiae has been shown to regulate
telomerase-mediated telomere elongation (15), a feature
that appears to be common among the telomere capping
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telomere maintenance is also suggested by studies showing
that combined loss of RPA and Ku70 in budding yeast
or RPA and Taz1 in ﬁssion yeast causes a telomere
shortening phenotype (21,22).
ALT cells and telomerase-positive cells may use diﬀer-
ent proteins for processing and protection of telomere
ends. This notion is supported by recent studies demon-
strating that the single-stranded telomere-binding protein
Cdc13, which is required for survival in S. cerevisiae,
becomes dispensable in post-senescence telomerase-
negative yeast strains (so-called type II survivors) that
use a telomerase maintenance strategy similar to that of
human ALT cells (23–25). In agreement with these studies,
we demonstrate here a telomere capping function of RPA
that appears to be speciﬁc for ALT tumor cells.
MATERIALS AND METHODS
Celllines
The cell lines GM-847 (SV40 transformed), U2OS
(osteosarcoma), HeLa (cerevical cancer), HaCaT (immor-
talized keratinocytes), SK-LU-1 (non-small cell lung
cancer), GM-637 (SV40 transformed) and G292 (osteo-
sarcoma) were cultured in Iscove’s modiﬁed Dulbecco’s
medium (IMDM) (BioWhittaker, Verviers, Belgium)
containing 10% fetal calf serum (FCS) (BioWhittaker).
HEK293 (adenovirus transformed kidney cells) and U87
(glioblastoma) cells were grown in Dulbecco’s modiﬁed
essential medium (DMEM) (BioWhittaker) containing
10% FCS. WI-38-VA13 (SV40 transformed ﬁbroblasts)
was grown in Eagle minimal essential medium (EMEM)
(BioWhittaker) containing 10% FCS, and SA-OS-2
(Osteosarcoma) and MCF-7 (breast cancer) were grown
in RPMI 1640 (BioWhittaker) containing 10% FCS.
Plasmids
Myc epitope-tagged RPA70 was generated by inserting
a PCR-generated KpnI–NotI fragment containing the
RPA70 coding region into pEF6/myc-His C (Invitrogen,
Carlsbad, California). Myc epitope-tagged RPA32 was
generated by inserting a PCR-generated KpnI–BstEII
fragment containing the RPA32 coding region into pEF6/
myc-His C (Invitrogen). All plasmid transfections were
performed using the FUGENE6 reagent (Invitrogen).
siRNAs
Cells were transfected using the Oligofectamine transfec-
tion reagent (Invitrogen) as described previously (26).
Transfected cells were analyzed on Day 3 following
transfection. Target sequences were
RPA32#1: GGCTCCAACCAACATTGTT (Ambion)
RPA32#2: GCCTGGTAGCCTTTAAGAT (Ambion)
RPA70#1: GCACTATCATTGCGAATCC (Ambion)
RPA70#2: CACTCTATCCTCTTTCATG (Ambion)
Luciferase (GL2): CTTACGCTGAGTACTTCGA
(Eurogentec, Seraing, Belgium)
The RPA32#1 and RPA70#1 targets were used
throughout the article. The additional targets (RPA32#2
and RPA70#2) were used in Supplementary Figure S1.
BrdU labeling,immunofluorescence (IF) and
laser scanning cytometry (LSC)
IF labeling of cells was performed as previously described
(27). To detect ssDNA within PML-NBs, cells grown on
coverslips were treated with 10mM BrdU for 24h (from
Day 2 to Day 3 after transfection with siRNAs) prior to
ﬁxation and IF labeling. Cells were prepared for LSC
analysis by staining the DNA with TO-PRO-3 (Invitrogen)
as previously described (26). Rabbit polyclonal antibodies
used were anti-PML (H238; Santa Cruz Biotechnology,
Santa Cruz, California). Mouse monoclonal antibodies
used were anti-PML (PG-M3; Santa Cruz Biotechnology),
anti-RPA32 (Ab-3; Calbiochem, San Diego, California),
anti-RPA70 [2H10 (28)], anti-BrdU (Amersham
Buckinghamshire, UK), anti-myc (Invitrogen) and anti-
TRF2 (Upstate, Waltham, Massachusetts).
Fluorescence insitu hybridization (FISH)-IF
Combined FISH and IF was performed as described
previously (27) with some modiﬁcations. Cells grown on
coverslips were ﬁrst ﬁxed in 1.5% paraformaldehyde
(PFA) in PBS for 5min and permeabilized in 0.5%
Triton X-100 in PBS for 4min. Subsequently, the cells
were stained using rabbit anti-PML (H238; Santa Cruz)
or anti-RPA32 (Ab-3; Calbiochem) and ﬁxed again in
4% PFA to cross-link bound antibodies. Cells were then
treated with 0.2mg/ml RNase (Sigma, St Louis, MO) in
2 SSC at 378C for 15min and washed three times in PBS.
The telomere-speciﬁc probe used in combination with
anti-RPA32 was a FITC-conjugated C-rich peptide nucleic
acid (PNA) probe (OO[CCCTAA]3) from Applied
Biosystems (Foster City, California). The probes used in
combination with anti-PML were digoxigenin (DIG)
labeled (TTAGGG)3 or (CCCTAA)3. Probes were ethanol
precipitated with 20 Cot-1 DNA and diluted in hybridi-
zation mix (50% deionized formamide, 10% dextran
sulfate, 2 SSC) to a ﬁnal concentration of 0.6mg/ml.
The probe was denatured for 5min at 708C and cooled to
378C before use. Cells on coverslips were immersed in
hybridizationmix,andthecellular DNAwasdenaturedfor
5min at 808C before hybridization at 378C in a humid
environment overnight. For hybridization at native condi-
tions, the denaturing step at 808C was omitted. Following
hybridization, the coverslips were washed three times for
10min in 0.1 SSC. The DIG-labeled probes were detected
by IF as described above using a monoclonal anti-DIG
antibody (Roche, Basel, Switzerland).
For preparation of metaphase spreads cells grown in
6cm dishes were transfected with siRNAs. On Day 3
following transfection, cells were treated with 50ng/ml
colcemid for 1h and subsequently subjected to hypotonic
swelling in 75mM KCl at room temperature for 15min.
Cells were then ﬁxed and stored in methanol/acetic acid
according to standard procedures (29). Telomere-FISH
was then performed using the FITC-conjugated PNA
7268 Nucleic Acids Research, 2007, Vol. 35, No. 21probe from Applied Biosystems essentially as described
previously (30).
Protein extraction and western blotting
Following transfection in 6cm culture dishes, cells were
detached from the plates by trypsin treatment, washed
twice in PBS and subsequently suspended in lysis buﬀer
(20mM Tris, pH 7.5, 0.42M KCl, 25% glycerol, 0.1mM
EDTA, 5mM MgCl, 0.5% Triton X-100, 1mM DTT,
0.5mM PMSF, 1mg/ml leupeptin, 1mg/ml aprotinin).
Following incubation on ice for 30min, samples were
centrifuged at 12 000xg for 10min and the supernatant
was collected. SDS–PAGE and western blots were
performed using NuPAGE 4–12% gradient Bis-Tris gels
(Invitrogen). Antibodies used were mouse monoclonal
anti-RPA32 (Ab-3; Calbiochem), mouse monoclonal anti-
RPA70 (2H10) and goat anti-b-actin (I-19; Santa Cruz
Biotechnology). Quantitative analysis of western blots was
achieved using the Multi Gauge software (Fugiﬁlm).
Pulse-field gelelectrophoresis and in-geldetection
of telomeric DNA
Total DNA was isolated from transfected cells using
the DNeasy tissue kit (Qiagen) and subsequently treated
with the restriction endonucleases HinfI and RsaI
(New England Biolabs). The digested DNA (3–5mg) was
fractionated on 1% Megabase agarose (Bio-Rad) using
the CHEF-DRIII system (Bio-Rad). Electrophoresis was
performed in 0.5 TBE, at 148C for 11h using 1–6s
switch time and a 1208 angle. In-gel hybridization was
then performed essentially as described (31). Brieﬂy gels
were dried on ﬁlter paper at 508C until completely dry.
The gels were rehydrated by soaking in deionized water.
Gels were prehybridized in Church buﬀer (0.5M
Na2HPO4 pH 7.2, 1mM EDTA, 7% SDS, 1% BSA) for
30min at 508C and hybridized at 508C overnight in the
same buﬀer containing a g-
32P-ATP-labeled (CCCTAA)3
or (TTAGGG)3 telomeric probe. Gels were washed three
times for 30min in 4 SSC at room temperature and
once in 4 SSC at 558C for 1h and exposed to a
PhosphorImager screen overnight. Following exposure,
gels were denatured by incubating in 0.5M NaOH, 1.5M
NaCl for 30min and neutralized in buﬀer containing
0.5M Tris–HCl pH 7.5, 1.5M NaCl for 20min. Gels were
then rehybridized to the same probe overnight in Church
buﬀer and subsequently washed as described above for
the ﬁrst hybridization.
Analysis ofextrachromosomal telomeric DNA
by neutral–neutral two-dimensional agarose
gel electrophoresis
Extrachromosomal DNA was isolated from cells grown
in 6cm culture dishes as described previously using a
modiﬁed Hirt-extraction procedure (27). Puriﬁed DNA
(3 mg) was fractionated by two-dimensional gel electro-
phoresis essentially as described previously (32). In brief,
fractionation in the ﬁrst dimension was performed in 0.4%
agarose in 1 TBE at 1V/cm for 18h. The gel was then
incubated in 1 TBE buﬀer containing 0.3mg/ml ethidium
bromideandexposedtoUVlightinordertoexcisethelines
of interest. The second dimension was run in 1% agarose in
1 TBE containing 0.3mg/ml ethidium bromide at 5V/cm
for 3.5h at 48C. The gels were illuminated with UV light,
photographed, and subsequently subjected to in-gel hybri-
dization as described above.
Microscopy
Microscopic images were acquired using a Zeiss LSM 510
Meta laser confocal microscope connected (Jena,
Germany) to a 63 oil immersion objective (Zeiss).
Fluorescence intensity diagrams were generated using
the Zeiss LSM image examiner software.
RESULTS
In the present study, we found that diﬀerent cell lines
exhibit a diﬀerence in the ability to sequester RPA32
within PML-NBs. For example, the ALT cell lines,
GM-847 and U2OS, were found to contain PML-NB-
associated RPA32 foci in 15–60% of the cells, whereas the
telomerase-positive cell lines, HeLa and MCF-7, did not
contain such foci and exhibited a dispersed nuclear
RPA32 staining pattern (Figure 1A).
To verify that localization of RPA to PML-NBs is
a characteristic speciﬁcally associated with cells that use
ALT, we examined the subnuclear distribution of RPA32
in a panel of cell lines with known telomere maintenance
mechanisms. We found that cell cultures using ALT
consistently contained a relatively high fraction (15–90%)
of cells with RPA32-positive PML-NBs. In contrast, the
fraction of cells containing such foci was considerably
lower (below 5%) in all of the telomerase-positive cells
tested (Figure 1B).
To further demonstrate a diﬀerence between ALT cells
and telomerase-positive cells in the ability to sequester
RPA within PML-NBs, we ectopically expressed myc-
tagged RPA32 or RPA70 in ALT and non-ALT cell lines.
Both of the expressed RPA subunits colocalized with
PML-NBs in more than 20% of transfected U2OS or
GM-847 cells, whereas the non-ALT cell lines, HeLa and
MCF-7, generally exhibited a dispersed nuclear distribu-
tion of ectopically expressed RPA (Figure 1C).
The observation that RPA associates with PML-NBs
in ALT cells, and not in telomerase-positive cells, is in
accordance with a previous study showing that this
protein represents one of the constituents of APBs (7).
We therefore performed FISH on asynchronous growing
U2OS and GM-847 cells to verify that the RPA-
containing nuclear structures contained telomeric DNA.
We found that nearly 100% of the RPA32 foci detected in
these cells colocalized with telomere repeat sequences
(Figure 1D). This result shows that the RPA-containing
foci detected in ALT cell lines are equivalent to APBs and
implicates a role of RPA in the ALT mechanism.
To study the function of RPA in ALT, we transfected
four diﬀerent cell lines, including two ALT cell lines
(GM-847 and U2OS) and two telomerase-positive cell
lines (HeLa and MCF-7), with a control siRNA against
luciferase (GL-2) or siRNAs targeting either RPA32
or RPA70. All four cell lines showed reduced RPA
Nucleic Acids Research, 2007, Vol. 35, No. 21 7269expression at 48h following transfection with RPA-
speciﬁc siRNAs (Figure 2; see Supplementary Figure 1
for quantiﬁcation of RPA expression). The siRNA against
RPA32 caused decreased expression of both RPA32 and
RPA70. This phenomenon was noted also in a previous
study and may reﬂect a role of RPA32 in stabilizing the
RPA complex (33).
We ﬁrst analyzed the telomeres in RPA-depleted
and control-depleted cells using telomere restriction
fractionation by pulse-ﬁeld gel electrophoresis and
subsequent in-gel hybridization under either native or
denaturing conditions. Hybridization under native condi-
tions revealed an increase in single-stranded G-rich
telomeric DNA in GM-847 and U2OS cells following
reduction of RPA32 or RPA70 expression (Figure 3A,
upper panels, lanes 13–18). In contrast, we detected no
changes in exposed G-rich telomeric ssDNA in response
to RPA loss in the non-ALT cell lines HeLa or MCF-7
Figure 1. RPA foci that colocalize with PML-NBs are formed in ALT cells, but not in telomerase-positive cells. (A) HeLa, MCF-7, GM-847 and
U2OS cells were grown on coverslips, ﬁxed, and ﬂuorescently labeled using antibodies against PML (red) and RPA32 (green). DAPI is shown in blue
in the merged images. (B) Quantiﬁcation of cells with RPA32-containing foci in ALT and non-ALT cell lines. Cells that contained one or more
distinct RPA32 focus that colocalized with a PML-NB were scored. For each sample, between 600 and 800 cells were examined. Data represent two
independent experiments standard deviation (SD). (C) Visualization of ectopically expressed myc-tagged RPA32 and RPA70 in ALT and non-ALT
cell lines. Myc-tagged proteins and PML-NBs were ﬂuorescently labeled using anti-myc (green) and anti-PML (red) antibodies, respectively.
(D) Asynchronous GM-847 and U2OS cells grown on coverslips were subjected to FISH-IF using a FITC-conjugated telomeric PNA probe (green)
and anti-RPA32 (red).
7270 Nucleic Acids Research, 2007, Vol. 35, No. 21(Figure 3A, upper panels, lanes 1–6). In the ALT cells we
also detected single-stranded C-rich telomeric DNA, but
in this case we did not observe an increase following
targeted depletion of RPA (Figure 3A, upper panels, lanes
19–24). In contrast, we did not detect single-stranded
C-rich telomeric DNA in the non-ALT cell lines MCF-7
and HeLa (Figure 3A, upper panels, lanes 7–12).
Interestingly, a large proportion of the single-stranded
telomeric DNA detected in RPA-depleted ALT cells was
retained near the well of the gel (Figure 3A, lanes 13–24).
Such high molecular weight telomeric DNA species
that do not enter the gel during electrophoresis are
commonly detected in ALT cells by telomere restriction
analysis and may represent complex recombination inter-
mediates (7). This observation may indicate that RPA loss
mainly aﬀects DNA that is engaged in recombinational
telomere elongation. Interestingly, hybridization at
denatured conditions also revealed a net increase of
these slow-migrating DNA species suggesting that RPA
may prevent their formation (Figure 3A, lower panels,
lanes 13–24). The increase in G-rich telomeric ssDNA
detected in these experiments was not due to oﬀ-target
eﬀects caused by the siRNAs used, as the same result was
obtained by using a second set of siRNAs targeting
diﬀerent regions of the RPA32 and RPA70 mRNA
sequence (Supplementary Figure S2).
To determine if RPA loss in ALT cells aﬀected the
integrity of extrachromosomal telomeric DNA, we ana-
lyzed low molecular weight DNA isolated from trans-
fected GM-847 cells using the Hirt extraction procedure.
For these experiments, the puriﬁed DNA species were
fractionated by two-dimensional gel electrophoresis to
allow separation of circular and linear as well as single-
stranded and double-stranded DNA species (Figure 3B).
Native in-gel hybridization using a C-rich telomeric probe
revealed an increase in the level of single-stranded G-rich
extrachromosomal telomere repeats following RPA loss
(Figure 3B, panels g–i). Conversely, we detected no
increase in single-stranded C-rich extrachromosomal
DNA following RPA depletion (Figure 3B, panels a–c).
Similar results were obtained by analyzing extrachromo-
somal DNA isolated from RPA- and control-depleted
U2OS cells (Supplementary Figure S3). We did not detect
any increase or decrease in the amount of circular double-
stranded telomeric DNA in cells with reduced RPA
expression (Figure 3B, Panels d–f and j–l). Although the
Hirt extraction procedure is highly selective for low
molecular extrachromosomal DNA, we cannot exclude
the possibility that some of the telomeric DNA detected in
these samples is of genomic origin as single-stranded DNA
is expected to be particularly sensitive to shearing forces.
Due to the central role of RPA in DNA replication,
reduced expression of this protein complex is expected to
cause defects in DNA synthesis and, consequently,
replication stress. To assess the possibility that the
increase in single-stranded telomeric DNA is caused by
frequent replication fork stalling or inhibition of DNA
synthesis, we treated the ALT cell line U2OS with diﬀerent
concentrations of the DNA synthesis inhibitors hydro-
xyurea or aphidicolin and subsequently determined the
level of single-stranded G-rich telomeric DNA. The DNA
synthesis inhibitors did not cause a signiﬁcant change in
the levels of single-stranded G-rich telomeric DNA neither
at low concentrations of the drugs that will cause frequent
replication fork stalling and replication stress, nor at
higher concentrations that is expected to cause severe
inhibition of DNA synthesis (Supplementary Figure 4).
Previous studies have shown that loss of Cdc13 in
S. cerevisiae or Pot1 in chicken causes an increase in
single-stranded telomeric DNA and subsequent activation
of cell cycle checkpoints (34,35). Furthermore, siRNA-
mediated depletion of RPA70 in HeLa cells has been
found to cause checkpoint activation and cell cycle arrest
in G2/M phase at Day 4 following transfection (33,36).
To determine the eﬀect of RPA loss on cell cycle progres-
sion under the conditions used in the present study,
we analyzed cell cycle distribution in control and
RPA-depleted cells at Day 3 following siRNA
Figure 2. SiRNA depletion of RPA32 and RPA70 in ALT and
telomerase-positive cell lines. Cells were transfected with the siRNAs
indicated and subsequently harvested at 48, 72 and 96h post-
transfection. Western blots were probed with antibodies against
RPA70 and RPA32. Blots were then stripped and subsequently
re-probed with antibodies against b-actin. Luciferase siRNAs (GL-2)
were used as a control. A quantitative representation of these data is
presented in Supplementary Figure S1.
Nucleic Acids Research, 2007, Vol. 35, No. 21 7271Figure 3. Depletion of RPA32 or RPA70 in ALT cells leads to increased levels of single-stranded G-rich telomeric DNA. Luciferase siRNA (GL2)
was used as a control. (A) Analysis of telomere restriction fragments by pulse-ﬁeld gel electrophoresis and in-gel hybridization. The gels were ﬁrst
hybridized using native conditions (upper panels). The same gels were subsequently denatured and then rehybridized to the same probes
(lower panels). A C-rich ([CCCTAA]3) or a G-rich ([TTAGGG]3) telomere-speciﬁc probe was used. Arrows indicate the position of the wells.
(B) Analysis of Hirt-extracted extrachromosomal DNA from GM-847 cells by two-dimensional agarose gel electrophoresis and in-gel hybridization.
Gels were ﬁrst hybridized to telomere-speciﬁc probes using native conditions. The same gels were then denatured and rehybridized using the same
probe. Triplicate panels were equally exposed.
7272 Nucleic Acids Research, 2007, Vol. 35, No. 21transfection. Both ALT cell lines (GM-847 and U2OS)
showed an increase of cells in late S and G2/M phase in
response to RPA loss (Figure 4). The arrest was less
pronounced in RPA32-depleted cells compared to
RPA70-depleted cells, possibly due to a role of RPA32
(but not RPA70) in activating the G2/M checkpoint. In
contrast to the ALT cells, we did not observe a dramatic
alteration in the cell cycle distribution following transfec-
tion of the telomerase-positive cell lines, MCF-7 and
HeLa, with siRNAs against RPA (Figure 4). Thus, ALT
cells appear to arrest more readily than the telomerase-
positive cell lines in G2/M phase following RPA loss.
We next analyzed the eﬀect of RPA depletion on the
nuclear localization of telomeric DNA using FISH.
Also for these experiments samples were hybridized at
both native and denatured conditions and by using probes
speciﬁc for both telomeric strands (Figure 5A). Loss of
RPA70 or RPA32 did not cause a signiﬁcant increase
in the number of cells containing detectable telomeric
DNA within PML-NBs (Figure 5B). However, the telo-
meric hybridization signal within individual PML-NBs
was considerably intensiﬁed following RPA depletion
(as indicated by the increase in telomere hybridization
(red) relative to the PML staining (green) in Figure 5C and
Supplementary Figure S5). This eﬀect was evident using
both C- and G-rich telomeric probes and for hybridization
of both native and denatured samples (Figure 5C and
Supplementary Figure S5).
We next assessed the eﬀect of RPA depletion on the
distribution of the general pool of ssDNA. For this
experiment we employed a previously described ssDNA
detection assay, which is based on metabolic labeling
of cells with bromodeoxyuridine (BrdU) and subsequent
detection of BrdU-containing ssDNA by ﬂuorescence
labeling under non-denaturing conditions (26). We found
that siRNA-mediated knockdown of RPA32 or RPA70 in
the ALT cell lines GM-847 and U2OS caused a consider-
able increase in the number of cells containing detectable
ssDNA within PML-NBs (Figure 5D and E). These
ssDNA foci were found to colocalize with the telomere-
binding protein TRF2 in more than 90% of the cells
examined, indicating that the ssDNA detected was
telomeric (Figure 5D, upper panels). We observed a
modest increase in cells containing ssDNA within
PML-NBs following transfection of the non-ALT cell
line MCF-7 with RPA32- and RPA70-speciﬁc siRNAs
(Figure 5E). However, in these cases we detected only one
or two ssDNA-positive PML-NB per nucleus, and they
were never found to colocalize with TRF2 (data not
shown). HeLa cells were virtually devoid of ssDNA foci
both before and after depletion of RPA32 or RPA70
(Figure 5E).
We concluded from these experiments that RPA loss
in ALT cells leads to an increase of telomere DNA repeats
within PML-NBs. Furthermore, since these telomeric
DNA species are detected under both native and denatur-
ing hybridization conditions, and because of the general
increase of ssDNA within this nuclear compartment
following RPA loss, a proportion of the telomeric DNA
residing in PML-NBs subsequent to RPA depletion is
likely to be single stranded.
We then analyzed the telomeres in metaphase spreads
prepared from control and RPA32-depleted cells using
FISH. We made attempts to analyze spreads prepared
from RPA70-depleted cells, but this proved diﬃcult due to
a low frequency of metaphases. In the RPA32-depleted
U2OS and GM-847 cells, we detected telomere signals in
metaphases that had the same shape and ﬂuorescence
intensity as those detected in interphase cells (Figure 6A,
arrows). In most cases these abnormally strong telomere
signals were found to associate with chromosomal ends,
indicating they may represent very large telomeres.
Furthermore,  30% of these telomeric aggregates
appeared to have connections with more than one
chromosomal end, suggesting that they may be involved
in telomeric recombination events (Figure 6A, bottom
panels). To quantify the occurrence of these large telomere
aggregates, we analyzed 20 metaphases from each of the
transfected samples. We found that reduced RPA32
expression in GM-847 and U2OS cells caused a consider-
able increase in the number of the abnormally intense
telomeric signals, suggesting that RPA prevented their
formation (Figure 6B). Large telomere aggregates at
chromosomal ends were not detected in the non-ALT
cells HeLa or MCF-7 (data not shown).
We also noted other chromosomal aberrations in
metaphases prepared from RPA32-depleted cells, includ-
ing chromosomal breakage and fragmentation. However,
these aberrations were detected with approximate
equal frequency in both the ALT and non-ALT cell lines
suggesting that they may be caused due to a general defect
in DNA repair or DNA replication (data not shown).
Figure 4. RPA loss in ALT cells causes cell cycle arrest in G2/M phase.
Cells on coverslips were transfected by the indicated siRNAs and
subjected to laser scanning cytometry on Day 3 following transfection.
Nucleic Acids Research, 2007, Vol. 35, No. 21 7273Figure 5. APBs accumulate ssDNA in response to RPA loss. (A) FISH analysis showing colocalization of telomeres and PML-NBs in U2OS cells
transfected with control siRNAs (GL2) and siRNAs against RPA32 and RPA70. Cells were hybridized under native and denaturing conditions, with
either a G-rich ([TTAGGG]3) or a C-rich ([CCCTAA]3) telomeric probe. (B) Quantiﬁcation of U2OS cells containing detectable telomeric signals
that colocalize with PML-NBs. Cells containing one or more telomeric signal that colocalize with a PML-NB were scored. For each sample between
70 and 80 cells were examined. Data represent two independent experiments SD. (C) Fluorescence intensity diagram of telomeric DNA and PML
in siRNA-transfected cells. Red (telomeric DNA), green (PML) and blue (DAPI) is overlaid in each of the images. The intensity diagrams shown in
the lower panels are plotted against the red line shown in the upper panels. Telomere signal is represented by red curves and PML signal is
represented by green curves. The example shows U2OS cells hybridized using a C-rich probe at native conditions. The complete ﬁgure showing all of
the hybridization conditions is shown in Supplementary Figure S5. (D) Visualization of single-stranded DNA in control-depleted or RPA-depleted
U2OS cells using anti-BrdU antibodies in combination with anti-TRF2 (upper panels) or anti-PML (lower panels). (E) Quantiﬁcation of ssDNA foci
that colocalize with PML-NBs in control-transfected cells (GL2) and cells transfected with RPA32- and RPA70-speciﬁc siRNAs. Cells containing one
or more distinct ssDNA foci within a PML-NB were scored. For each sample 600 to 800 cells were examined. Data represent two independent
experiments SD.
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In the present study, we have shown that loss of RPA
in human ALT tumor cells causes an increase in single-
stranded G-rich telomeric DNA, cell cycle arrest in
G2/M phase, increased accumulation of telomeric DNA
within APBs and generation of large telomeric
aggregates that associate with the ends of metaphase
chromosomes. The mechanism by which RPA interacts
with telomeres in order to prevent the onset of these
phenotypes may be similar to that of other single-stranded
Figure 6. Loss of RPA causes formation of telomere aggregates at chromosomal ends. U2OS and GM-847 cells were transfected with control (GL2)
siRNAs or siRNAs speciﬁc for RPA32. On Day 3 following transfection metaphase spreads were prepared and telomeres were visualized using a
C-rich ([CCCTAA]3) telomeric PNA probe. (A) Visualization of telomeres in metaphase and interphase of control-depleted (GL2) and RPA32-
depleted U2OS and GM-847 cells. Arrows point to abnormally strong telomere signals. Selected telomere fusions (numbered 1 to 3) are shown at
high magniﬁcation in the lower panels. (B) Quantiﬁcation of abnormally strong telomere signals in metaphase cells. For each sample 20 metaphase
spreads were scored.
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tural conservation between RPA and members of the
single-strand telomere-binding family of proteins (11,12),
and by studies also showing that S. cerevisiae Cdc13
and chicken Pot1 prevent exposure of single-stranded
G-rich telomere DNA and subsequent G2/M phase
arrest (34,37).
Loss of RPA in U2OS and GM-847 cells appears to
enhance several of the ALT-speciﬁc phenotypic features.
First, RPA depletion induces the formation of telomeric
DNA that has poor electrophoretic mobility in agarose
gels following treatment with restriction enzymes. Such
DNA fragments that are retained near the well of the gel
are normally detected in ALT cells and may represent
recombining DNA (7). Interestingly, a large proportion
of the single-stranded telomeric DNA that formed in
response to RPA loss was also found to associate with
these putative recombination intermediates. This observa-
tion may suggest that formation of the single-stranded
telomeric DNA in cells with reduced RPA expression is
coupled to recombinational telomere elongation.
The second ALT-speciﬁc characteristic that becomes
enhanced by reduced RPA expression is the presence of
telomeric DNA repeats within APBs. RPA depletion did
not lead to a signiﬁcant increase in the number of cells
containing detectable telomeric DNA within PML-NBs,
suggesting that RPA loss did not lead to a net increase
in the number of APBs. Rather, reduced expression of
this protein complex seemed to cause an increase in the
amount of telomeric DNA present within pre-existing
APBs. RPA knockdown also caused accumulation of
single-stranded DNA within APBs as determined by
native IF labeling of metabolically incorporated BrdU.
However, despite the clear increase of single-stranded
G-rich versus C-rich telomeric strands that was revealed
by in-gel hybridization, we were not able to demonstrate
a speciﬁc increase of single-stranded telomeric G-strands
within APBs using a native telomere FISH procedure
(hybridization without prior heat denaturing). This result
may be due to the presence of inherent denatured regions
of duplex telomeric DNA during the FISH procedure.
Alternatively, the increase in both G and C-strand signal
in APBs under these conditions may reﬂect a recruitment
mechanism that sequesters telomeric DNA within APBs,
and consequently intensiﬁes the signals from both strands.
Finally, analysis of metaphase spreads revealed that
loss of RPA in the ALT cell lines GM-847 and U2OS
caused an increase in large telomeric occlusions that
are associated with one or multiple chromosomal ends.
It is possible that these large telomeric structures consist
of extremely long telomeres that have been generated
at chromosomal ends. Alternatively, they may represent
aggregates of extrachromosomal telomeric repeats that are
contacting the ends of the chromosomes. The number and
size of these metaphase structures were similar to the
telomere aggregates detected in interphase cells within
APBs, suggesting that they may represent the same
structures. These observations are consistent with the
notion that APBs are in contact with one or several
chromosomal ends and that these nuclear compartments
represent sites of recombinational telomere elongation.
One possible mechanism for recombinational telomere
elongation in ALT cells that has received strong experi-
mental support is telomere synthesis by rolling-circle
replication (3–5,38–40). According to this model, rela-
tively large tracts of telomeric DNA can be synthesized
essentially in one step by using extrachromosomal circular
telomeres as a template. This mechanism is predicted to
cause an abrupt elongation of the telomere 30 overhang
and may therefore account for the increase in single-
stranded telomeric G-rich DNA that is seen in ALT cells
with reduced RPA expression. RPA may function to
inhibit initiation of such template-directed DNA synthesis
simply by preventing annealing of the single-stranded 30
telomeric overhang to partially single-stranded telomere
circles. Alternatively, RPA could occlude the single-
stranded telomeric DNA in a way that prevents Rad51-
mediated strand invasion of the 30 end into a duplex
telomere sequence. This latter possibility is consistent with
a previous study showing that RPA has the ability to
suppress direct-repeat recombination in S. cerevisiae (41).
The single-stranded G-rich DNA may also be formed
in RPA-depleted cells due to exposure of the C-rich
telomeric DNA to one or several 50 exonucleases. Such
protection of telomeres from C-strand resection has been
proposed to be an important function of S. cerevisiae
Cdc13, which together with Stn1 and Ten1 has been
suggested to form an RPA-like protein complex (12).
However, a role of RPA in protection from end resection
seems unlikely to be the full explanation for the increase
of telomeric DNA within PML-NBs and at chromosomal
ends, which can be observed in RPA-depleted ALT cells.
Nor does it explain why RPA loss aﬀects the level of
single-stranded G-rich telomeric DNA in ALT cells and
not in telomerase-positive cells.
The rolling-circle mechanism of telomere extension
also predicts the involvement of a helicase that unwinds
the duplex DNA ahead of the elongating strand.
Interestingly, a previous study has demonstrated that
overexpression of the Bloom syndrome helicase BLM
in the ALT cell line WI38-VA13 causes increased recruit-
ment of telomeric DNA to PML-NBs in a manner similar
to that observed in RPA-depleted ALT cells (42). Thus,
RPA and BLM may cooperate in the process of telomere
elongation in ALT cells. It is possible, for example, that
RPA has an inhibitory eﬀect on BLM at telomeric ends.
Until now, telomerase-mediated telomere elongation is
the only telomere maintenance strategy being actively
pursued as a target in cancer therapy. While such therapies
are expected to prevent growth of telomerase-positive
tumors, they are not likely to be eﬀective against
telomerase-negative cancer cells that use ALT. RPA
represents the ﬁrst example of a protein that is required
for telomere protection in cells employing the ALT
mechanism of telomere elongation. The present study
suggests that the development of potent therapeutic
strategies that speciﬁcally target tumor cells using ALT
may involve the exploitation of RPA.
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